Tumor-Infiltrating Lymphocyte (TILs)

Tumor-infiltrating lymphocyte (TILs) proportion and spatial location within the TME are evaluated in all breast cancer subtypes, where we show a higher number of TNBC patients had intra-tumoral TILs - an observation unique to the cohort from India. Within TNBC, a higher proportion of stromal TILs predicted better response to chemotherapy and longer disease-free survival.